MedTrace Logo

Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk

NCT06670677 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2025-05-14

No results posted yet for this study

Summary

Because Aktiia S.A. has been the first-ever company to put in the market an Optical Blood Pressure Monitoring device, there is a need for Aktiia S.A. to correlate for the first time continual Blood Pressure monitoring and the evolution of environmental and health factors to improve hypertension management.

Conditions

  • Hypertension
  • Cardiovascular Risk
  • Blood Pressure Check (Hypertension Screening)

Interventions

OTHER

Lifestyle survey completion

For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.

OTHER

Unlimited on-demand blood pressure measurements with G2C

For the next 10 years: take unlimited on-demand measurements with the Aktiia G2C feature (finger measurement) while seated

OTHER

Continual blood pressure measurements with G1

For the next 10 years: wear their 24/7 Aktiia G1 device continuously as they would outside the context of the research project.

Sponsors & Collaborators

  • Aktiia SA

    lead INDUSTRY

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-12
Primary Completion
2035-05-31
Completion
2035-05-31

Countries

  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06670677 on ClinicalTrials.gov